About Stavanger Helseforskning
Clinical Trials at Stavanger Helseforskning
During the past decade, Stavanger Helseforskning conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Stavanger Helseforskning"
#1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Stavanger Helseforskning
According to Clinical.Site data, the most researched conditions in "Stavanger Helseforskning" are
"Atrial Fibrillation" (1 trials), "Congestive Heart Failure" (1 trials), "Diabetes Mellitus, Type 1" (1 trials) and "Percutaneous Coronary Intervention" (1 trials). Many other conditions were trialed in "Stavanger Helseforskning" in a lesser frequency.
Clinical Trials Intervention Types at Stavanger Helseforskning
Most popular intervention types in "Stavanger Helseforskning" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Aspirin" (1 trials), "Clopidogrel or Ticagrelor" (1 trials), "Dabigatran Etexilate 110mg" (1 trials), "Dabigatran Etexilate 150mg" (1 trials) and "Empagliflozin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Stavanger Helseforskning
The vast majority of trials in "Stavanger Helseforskning" are
3 trials for "All" genders.
Clinical Trials Status at Stavanger Helseforskning
Currently, there are NaN active trials in "Stavanger Helseforskning".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Stavanger Helseforskning,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Stavanger Helseforskning, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".